Low-Frequency Sensorineural Hearing Loss Associated With Iron-Deficiency Anemia

Taki, Masato; Hasegawa, Tatsuhisa; Ninoyu, Yuzuru; Mohri, Hiroaki; Hirano, Shigeru

doi:10.5152/iao.2021.9369

Cited by 4 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The main recognised pathogenetic mechanisms include mechanical obstruction of the endolymphatic vessels and impaired endolymphatic absorption, the immune response theory, and the inner ear ischaemia theory. Acute hypotonic sensorineural hearing loss is a syndrome with a distinctive clinical and auditory presentation, with ear congestion as the main symptom [ 10 , 11 ], an elusive cause, and the development of Meniere's disease if not treated promptly. It was suggested [ 12 ] that the disease is related to endolymphatic hydrops, and patients with acute low-tone sensorineural hearing loss are often associated with vestibular impairment regardless of the presence of vertigo.…”

Section: Discussionmentioning

confidence: 99%

The Relationship between Meniere’s Disease and Acute Low-Tone Sensorineural Hearing Loss

Li¹,

Han

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

Objective. To analyse the vestibular function characteristics of patients with Meniere's disease and acute hypophonic sensorineural hearing loss in order to find more reliable and objective ancillary tests that will reduce misdiagnosis and missed diagnoses. Methods. From January 2021 to December 2021, 60 healthy adults who underwent physical examination in our hospital were included in the control group, 60 patients with Meniere's disease were included in Study Group A, and 60 patients with acute low-tone sensorineural hearing loss were recruited in Study Group B. All participants underwent the caloric test (CT), video-head impulse test (vHIT), headshaking test (HST), and vestibular-evoked myogenic potential (VEMP) testing, which includes ocular vestibular-evoked myogenic potential (oVEMP) and cervical vestibular-evoked myogenic potential (cVEMP). Results. Statistical analyses of unilateral weakness and directional preponderance (DP) in the two groups of patients found no significant differences between the two groups ( P > 0.05 ). There was no statistically significant difference in the abnormal rate of vHIT and HST results between the two study groups ( P > 0.05 ). There was no significant difference in the wave latencies, interwave intervals, and amplitudes of cVEMP and oVEMP, among the three groups ( P > 0.05 ). Conclusion. This study found that factors affecting CT, vHIT, HST, and VEMP results included age, head posture and position during testing, stimulus type, manipulation method, and control of muscle tone, and also those that are related to the testing instrument, statistical software, and manipulation procedures, resulting in different excitation rates and testing parameters. The small sample size prevented a comprehensive assessment of the differences in vestibular function between patients with Meniere's disease and acute hypotonic sensorineural hearing loss, and a larger sample size will be investigated in the future to provide useful insight into the diagnosis, treatment and differentiation of Meniere’s disease, and acute hypotonic sensorineural hearing loss.

show abstract

Section: Discussionmentioning

confidence: 99%

The Relationship between Meniere’s Disease and Acute Low-Tone Sensorineural Hearing Loss

Li¹,

Han

et al. 2022

Evidence-Based Complementary and Alternative Medicine

View full text Add to dashboard Cite

show abstract

“…Despite this, multiple studies have linked cochlear hydrops and ALHL to the early onset of Meniere's illness. 13 Abe as quoted by Sato reported a study of 39 patients with ALHL with unclear causes. All patients experience complete healing without recurrence and symptom fluctuations.…”

Section: Discussionmentioning

confidence: 96%

Management of Bilateral Acute Low Tone Sensorineural Hearing Loss (ALHL)

Yoanita,

Rosalinda

2023

Advances in Health Sciences Research

View full text Add to dashboard Cite

Introduction:In the ORL-HNS, acute low-tone sensorineural hearing loss (ALHL) is an emergency that needs to be treated right away. The hearing loss in ALHL is restricted to low-tone frequencies, and it has a superior prognosis compared to idiopathic sudden sensorineural hearing loss (ISSNHL). The administration of systemic corticosteroids was said to provide positive outcomes. Aim: to ascertain the effects of steroid treatment in patients with ALHL without diuretics. Case Report: A 36-year-old lady was identified as having dyslipidemia and bilateral acute low-tone sensorineural hearing loss. Patients had complete bed rest, oxygen treatment, simvastatin, vitamins B and C, and high-dosage oral corticosteroids (tapering off). Method: Through the Cochrane database, PubMed, and Google Scholar, evidence-based literature studies on the management of ALHL are available. Conclusion: The ORL-HNS department considers ALHL to be an emergency that needs to be treated right away to improve the prognosis. With corticosteroids as the primary treatment and no diuretics in combination, PTA has improved with favorable outcomes. It is essential to assess the effectiveness of therapy throughout both short-and long-term follow-ups.

show abstract

“…The concern is that, in pregnant women, IDA is associated with fetal growth retardation, the intellectual development of newborns, and high susceptibility to infections. Anemia is not only a kind of hematological disease but is also associated with sensorineural hearing loss [7] [8] [9], depression [10], thyroid dysfunction during pregnancy [11], fibromyalgia [12], venous thromboembolism [13], ischemic stroke [14], heart failure [15], cancer [16], affecting the treatment and prognosis of these diseases. Hence, correcting IDA is of great significance to improving the quality of life of the broad masses of people and reducing the occurrence of adverse events.…”

Section: Population Who Chinamentioning

confidence: 99%

Efficacy and Safety of Iron Isomaltoside Compared with an Oral Iron Supplement in the Management of Patients with Iron Deficiency Anemia

Wu,

Zhou,

et al. 2024

OJBD

View full text Add to dashboard Cite

Objective: To evaluate the treatment outcome of iron isomaltoside compared with an oral iron supplement in the management of iron deficiency anemia (IDA). Methods: The study included patients with IDA who visited the Outpatient Clinic of the Department of Hematology, the Affiliated Hospital of Qingdao University from October 2021 to August 2022 and met the inclusion and exclusion criteria. According to the actual application of iron supplementation, the patients were divided into two groups: iron isomaltoside treatment group and oral iron treatment group. Baseline measurements were collected before the start of treatment, and measurements were collected subsequently at intervals of 1 week, 1 month, and 3 months. The hematological parameters analyzed included Hemoglobin (Hb), Mean corpuscular hemoglobin (MCH), Mean Hemoglobin content (MCH), Mean corpuscular Hemoglobin concentration (MCHC), and Platelet (Plt). Safety data and adverse event profiles were recorded. Results: Intra-group comparisons: After 1 month of treatment, the Hb significantly improved (P < 0.05). Inter-group comparisons: The biochemical parameters were significantly improved (P < 0.05) in the iron isomaltoside group compared with those in the oral iron group after 1 month of iron supplementation in patients with mild and moderate anemia. Adverse reactions were tolerable for the patients in both iron isomaltoside group and oral iron group. Only 1 patient in iron isomaltoside group developed anaphylactic shock during medication and recovered after aggressive rescue. Conclusions: Iron isomaltoside which increases Hb more rapidly compared with the oral iron supplementation has few adverse reactions and good acceptance.

show abstract

Low-Frequency Sensorineural Hearing Loss Associated With Iron-Deficiency Anemia

Cited by 4 publications

References 11 publications

The Relationship between Meniere’s Disease and Acute Low-Tone Sensorineural Hearing Loss

The Relationship between Meniere’s Disease and Acute Low-Tone Sensorineural Hearing Loss

Management of Bilateral Acute Low Tone Sensorineural Hearing Loss (ALHL)

Efficacy and Safety of Iron Isomaltoside Compared with an Oral Iron Supplement in the Management of Patients with Iron Deficiency Anemia

Contact Info

Product

Resources

About